Clinical Trial Update: Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA [NA]

View source ↗

Summary

A clinical trial (ALCYTA) investigates adaptive antitumoral immune cells obtained through lymphapheresis in cancer patients and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Institut Curie | Conditions: Cancer, Immune System or Toxicities Suspected | NA | Status: RECRUITING